- The trend backdrop is active with a 10-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
LALPATHLAB
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Dr. Lal PathLabs Limited · Healthcare · Diagnostics & Research
Latest close
1,932 INR
1.4%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 27.1% above the Trend Line and sits at 96.6% of its 52-week range. The latest completed week returned 1.4%, after a 14.4% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 48/100. Near-term considerations: price is close to its 52-week high.
Setup score
77
out of 100
Latest Close
1,932 INR
7 Aug 2026
1W Return
1.4%
latest completed week
4W Return
14.4%
short-term follow-through
12W Return
20.8%
quarterly tape
Trend Breadth
51.9%
27 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- 3 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.4%
Latest completed week; four-week move 14.4%.
Indicator stack
63/80
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 55.33%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
48/100
9 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 27.1% above the Trend Line and sits at 96.6% of its 52-week range. The latest completed week returned 1.4%, after a 14.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9312-week average 0.63
12-week confirmation
Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.93Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers
No recent accumulation markers. 3 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 14.4% over four weeks, 20.8% over 12 weeks, and 21.7% over one year. The current trend has remained active for 10 consecutive weeks.
Performance by holding period
Active trend streak10 weeks
Active weeks in one year27
Trend breadth51.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.56Latest activity-pressure read.
Pressure change29.6%Four-week change in activity pressure.
Leadership26.71Latest relative-leadership reading.
RS change88.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 88%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength48/100Blend of value, momentum, and quality. Underlying universe rank 53; rank 1 is best.
Value11/100Relative valuation strength. Underlying universe rank 90; rank 1 is best.
Quality99/100Profitability and accounting quality. Underlying universe rank 2; rank 1 is best.
Momentum77/100Medium-term price momentum. Underlying universe rank 24; rank 1 is best.
Growth35/100Revenue and earnings growth. Underlying universe rank 66; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework57/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 63.9x Price divided by trailing earnings.
- Price / sales
- 11.7x Market value relative to trailing revenue.
- EV / EBITDA
- 37.8x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 1.4% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 80.6% Gross profit retained from each unit of revenue.
- Operating margin
- 37.1% Operating profit retained from revenue.
- Free-cash-flow margin
- 16.7% Free cash flow generated from revenue.
- Return on invested capital
- 31.2% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 12.3% Latest one-year revenue growth.
- EPS growth
- 3.5% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -10.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.8% Cash dividends relative to market value.
- Buyback yield
- -0.1% Net share repurchases relative to market value.
- Shareholder yield
- 0.8% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment48/100
Weighted news tone is neutral across 9 relevant articles.
1 positive · 7 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.2%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+20.7%Week of 8 May.
Worst week-4.4%Week of 5 Jun.
Latest week+1.4%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains9
Flat weeks0
Modest losses11
Sharp losses1
Recent vol3.4%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew3.4% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank10 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Diagnostics & Research
4-week rank3 / 9
Group average4.7%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD77.8%positive activity pressure
RS66.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape73/100
Trend, activity pressure, participation, and risk combine to a 73/100 tape read.
Indicator analysis80/100Latest 12-week confirmation: trend 10/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.93; 3 reversal markers Next-Week ExpectancyPositive 55.33%Next-week expectancy is positive with a 55.33% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors58/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 76 SVQF57/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 677.5 of 1589 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment48/100Weighted news tone is neutral across 9 relevant articles.
LALPATHLAB Outlook for the Week (August 10, 2026 – August 14, 2026) Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,932 INR | 1.4% | 1,520 INR | 1,410 INR | 1.56 | 26.71 | 2.1M | On |
| 31 Jul 2026 | 1,905 INR | 8.6% | 1,503 INR | 1,405 INR | 1.44 | 26.46 | 4.4M | On |
| 24 Jul 2026 | 1,755 INR | 4.3% | 1,488 INR | 1,400 INR | 1.22 | 20.00 | 2.1M | On |
| 17 Jul 2026 | 1,683 INR | -0.3% | 1,476 INR | 1,397 INR | 1.18 | 12.85 | 1.4M | On |
| 10 Jul 2026 | 1,688 INR | 2.9% | 1,467 INR | 1,393 INR | 1.20 | 14.15 | 2.0M | On |
| 3 Jul 2026 | 1,641 INR | -2.6% | 1,458 INR | 1,389 INR | 1.12 | 11.10 | 501.5K | On |
| 26 Jun 2026 | 1,685 INR | 3.2% | 1,454 INR | 1,386 INR | 1.04 | 15.49 | 0 | On |
| 19 Jun 2026 | 1,632 INR | 2.1% | 1,448 INR | 1,383 INR | 1.05 | 12.65 | 226.9K | On |
| 12 Jun 2026 | 1,598 INR | 4.2% | 1,446 INR | 1,379 INR | 1.14 | 12.49 | 192.4K | On |
| 5 Jun 2026 | 1,533 INR | -4.4% | 1,445 INR | 1,375 INR | 1.27 | 9.42 | 228.4K | On |
| 29 May 2026 | 1,604 INR | -1.4% | 1,446 INR | 1,371 INR | 1.56 | 13.89 | 1.3M | Off |
| 22 May 2026 | 1,626 INR | 1.7% | 1,444 INR | 1,367 INR | 1.30 | 15.12 | 1.6M | Off |
| 15 May 2026 | 1,599 INR | -2.8% | 1,441 INR | 1,363 INR | 1.22 | 13.99 | 2.4M | Off |
| 8 May 2026 | 1,646 INR | 20.7% | 1,439 INR | 1,359 INR | 0.99 | 15.20 | 11.4M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.